NT-proBNP, a biomarker frequently used in clinical practice for cardiovascular disease assessment, has proven to be an effective indicator for evaluating cardiac dysfunction or pulmonary hypertension in patients with COPD. This evidence concerns the gene NPPB and cardiovascular disorder.